| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.740 | 28.590 | 30.648 | 34.528 | 36.129 | 40.929 | 31.007 | 48.298 | 24.330 | 5.982 |
| Total Income - EUR | 3.740 | 28.831 | 30.648 | 34.777 | 36.181 | 40.982 | 39.050 | 48.360 | 24.361 | 6.132 |
| Total Expenses - EUR | 1.593 | 15.348 | 17.504 | 23.498 | 25.642 | 14.786 | 22.603 | 23.963 | 25.529 | 21.238 |
| Gross Profit/Loss - EUR | 2.146 | 13.483 | 13.143 | 11.279 | 10.539 | 26.196 | 16.448 | 24.396 | -1.167 | -15.105 |
| Net Profit/Loss - EUR | 2.034 | 12.618 | 12.553 | 10.932 | 10.177 | 25.808 | 16.057 | 23.922 | -1.374 | -15.105 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Med-Ginecolam Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 97 | 17.684 | 12.043 | 8.407 | 2.213 | 799 | 20.862 | 20.873 | 15.129 | 9.652 |
| Current Assets | 2.648 | 11.103 | 13.181 | 16.565 | 14.146 | 27.208 | 15.914 | 33.177 | 5.466 | 2.364 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 138 | 196 | 0 | 546 | 946 | 22.254 | 679 | 556 |
| Cash | 2.648 | 11.103 | 13.043 | 16.369 | 14.146 | 26.661 | 14.968 | 10.923 | 4.787 | 1.808 |
| Shareholders Funds | 2.079 | 14.675 | 14.056 | 10.975 | 10.220 | 25.849 | 29.204 | 23.963 | 20.494 | 5.274 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 666 | 14.112 | 11.175 | 13.997 | 6.140 | 2.158 | 8.116 | 30.411 | 341 | 6.981 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Med-Ginecolam Srl